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Abstract
We compared 2 rating scales with different manic symptom items on diagnostic accuracy for 
detecting pediatric bipolar spectrum disorder (BPSDs) in outpatient mental health clinics. 
Participants were 681 parents/guardians of eligible children (465 male, mean age = 9.34) who 
completed the Parent General Behavior Inventory-10-item Mania (PGBI-10M) and mania subscale 
of the Child and Adolescent Symptom Inventory-Revised (CASI-4R). Diagnoses were based on 
KSADS interviews with parent and youth. Receiver operating characteristic (ROC) analyses and 
diagnostic likelihood ratios (DLRs) determined discriminative validity and provided clinical 
utility, respectively. Logistic regressions tested for incremental validity in the CASI-4R mania 
subscale and PGBI-10M in predicting youth BPSD status above and beyond demographic and 
common diagnostic comorbidities. Both CASI-4R and PGBI-10M scales significantly 
distinguished BPSD (N=160) from other disorders (CASI-4R: Area under curve (AUC) = .80, p 
< .0005; PGBI-10M: AUC = .79, p < .0005) even though scale items differed. Both scales 
performed equally well in differentiating BPSDs (Venkatraman test p > .05). Diagnostic likelihood 
ratios indicated low scores on either scale (CASI: 0–5; PGBI-10M: 0–6) cut BPSD odds to 1/5 of 
those with high scores (CASI DLR− = 0.17; PGBI-10M DLR− = 0.18). High scores on either 
scale (CASI: 14+; PGBI-10M: 20+) increased BPSD odds about fourfold (CASI DLR+ = 4.53; 
PGBI-10M DLR+ = 3.97). Logistic regressions indicated the CASI-4R mania subscale and 
PGBI-10M each provided incremental validity in predicting youth BPSD status. The CASI-4R is 
at least as valid as the PGBI-10M to help identify BPSDs, and can be considered as part of an 
assessment battery to screen for pediatric BPSDs.
Keywords
bipolar disorder; adolescents; assessment; receiver operating characteristic; diagnostic likelihood 
ratio; CASI; PGBI-10M
Bipolar Spectrum Disorders (BPSDs) are characterized by abnormal and recurrent 
dysregulation of mood and energy (Goodwin & Jamison, 2007) and affect approximately 
1.8% of youth in the United States (Van Meter, Moreira, & Youngstrom, 2011). The term 
BPSDs includes several diagnoses that differ according to duration and severity of manic 
symptoms, (i.e., Bipolar I Disorder (BP-I), Bipolar II Disorder (BP-II), cyclothymic 
disorder, and Other Specified Bipolar and Related Disorders--known as Bipolar Disorder-
Not Otherwise Specified (BP-NOS) in DSM-IV-TR). BPSDs are correlated with a host of 
adverse outcomes in youth, including high rates of suicide attempts (Goldstein et al., 2012; 
Hauser, Galling, & Correll, 2013), alcohol and substance use (Stewart et al., 2012) and 
incarceration (Pliszka, Sherman, Barrow, & Irick, 2000). Despite severity of symptoms and 
adverse outcomes, diagnosing BPSDs continues to be challenging for clinicians (Miller, 
Johnson, Kwapil, & Carver, 2011). Individuals often remain in the mental health services 
system 5 to 15 years before an accurate diagnosis of a BPSD is made (Ghaemi, Boiman, & 
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Goodwin, 1999; Hirschfeld et al., 2003; Marchand, Wirth, & Simon, 2006), leading to 
inappropriate treatment and poorer outcomes. There is a crucial need for accurate screening 
tools that can be administered quickly to identify individuals at risk for BPSDs.
The diagnosis of BPSDs is particularly challenging in youth due to high comorbidity with 
disruptive behavior disorders and ADHD, which share symptoms with BPSDs (such as 
difficulty concentrating, impulsivity, and irritability). Consequently, these symptoms become 
a source of confusion when evaluating a child or adolescent using a single time point (Geller 
et al., 2002). Additionally, youth with BPSDs are often misdiagnosed with major depression 
(Chilakamarri, Filkowski, & Ghaemi, 2011; c.f. Pacchiarotti et al., 2013).
Many youth with BPSDs have a history of a depressive episode, and the onset of hypomanic 
symptoms following a depressive episode is likely to go unnoticed when a diagnosis of 
major depressive disorder is already present. This increases the likelihood that a more 
accurate diagnosis of BP-II disorder will not be made. Treatment of BPSDs with 
antidepressants has been found to be ineffective for ameliorating mixed states (Pacchiarotti 
et al., 2013). Treating BPSDs with antidepressants may exacerbate hypomanic/manic 
symptoms or cycling (Chilakamarri et al., 2011; cf. Joseph, Youngstrom, & Soares, 2009) or 
result in delays in receiving efficacious treatment. Considering that youth with BPSDs often 
present in a depressive episode, accurate screening tools for BPSDs can be useful in helping 
to identify such youth more quickly at the point of screening, as compared to only starting to 
identify them during more extensive diagnostic assessments.
However, diagnosing a patient who possibly has pediatric BPSD remains a challenging 
endeavor. Multiple screening tools are available to assess BPSD symptoms that could signal 
the need for more thorough evaluation (Youngstrom, Genzlinger, Egerton, & Van Meter, 
2015). Yet, little is known about how scores on these screening tools may change the 
probability of a BPSD diagnosis in youth. While an evidence-based approach to assessment 
(Straus, Glasziou, Richardson, & Haynes, 2011) improves accuracy of the estimated 
likelihood of a BPSD diagnosis, the information needed to take advantage of this approach 
is often unavailable. Providing diagnostic likelihood ratios (DLRs) for commonly used 
clinical tools and demonstrating how to integrate them into an evidence-based approach to 
assessment can potentially improve the assessment, diagnosis and treatment of BPSDs in 
youth.
Several well-established measures may possibly increase the likelihood of accurate 
assessment of BPSDs in children and adolescents, such as the parent-reported General 
Behavior Inventory (P-GBI; Youngstrom, Findling, Danielson, & Calabrese, 2001), its 10-
item version (PGBI-10M; Youngstrom, Frazier, Demeter, Calabrese, & Findling, 2008), a 
brief version of the Child Mania Rating Scale-Parent version (CMRS-P; Henry et al., 2008) 
and the parent-reported Mood Disorder Questionnaire (P-MDQ; Wagner et al., 2006). A 
recent meta-analysis by Youngstrom et al. (2015) established the status of these three 
assessments as top tier measures in terms of discriminative validity for pediatric BPSD. The 
PGBI-10M abbreviated the P-GBI by focusing on the 10 items that best discriminated 
BPSDs from other outpatient diagnoses, hence optimizing its value as a screening tool for 
detecting BPSDs.
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Each of these three measures possesses different advantages. For instance, the P-GBI 
demonstrates exceptionally high internal consistency and reliability, high diagnostic 
efficiency and an ability to differentiate accurately between BPSDs and ADHD, arguably 
one of the most difficult differential diagnoses to make (Galanter & Leibenluft, 2008; Geller 
et al., 2002). Such measures with mania-specific items have performed significantly better 
(Youngstrom et al., 2004) than established and commonly-used broad-coverage measures 
that do not include scales that specifically screen for mania, such as the Child Behavior 
Checklist (CBCL; Achenbach & Rescorla, 2001), though the latter has been widely 
researched for assessment of multiple disorders. However, since evidence-based assessment 
approaches do not recommend specific screening for a particular disorder, but rather leading 
with a broad test that assesses more common diagnostic issues (Jenkins, Youngstrom, 
Washburn, & Youngstrom, 2011; Youngstrom, Choukas-Bradley, Calhoun, & Jensen-Doss, 
2014), there is a need to embed a mania scale in broad, frontline assessments.
The CASI-4R Mania Subscale
The Child and Adolescent Symptom Inventory-Revised (CASI-4R; (Gadow & Sprafkin, 
2005) is a broad assessment tool that may fill a gap in the current evidence-based toolkit. 
First, the CASI-4R consists of symptom modules that can be scored to derive symptom 
counts that map to a DSM-IV-TR (American Psychiatric Association, 2000) diagnosis, 
giving the CASI-4R high content validity (Sprafkin, Steinberg, Gadow, & Drabick, 2013). 
Second, the CASI-4R combines items from both the Child Symptom Inventory-4 (CSI-4) 
and the Adolescent Symptom Inventory (ASI-4; Gadow & Sprafkin, 2005), making it useful 
as a developmentally appropriate screening tool for both children and adolescents. Third, the 
CASI-4R also provides a dimensional perspective via severity scores (Sprafkin et al., 2013). 
Fourth, akin to current frontrunners of BPSD assessment, such as the PGBI-10M, the 
CASI-4R mania subscale (which is derived from the CASI-4R questionnaire) is efficient to 
administer, with only nine questions on the subscale. Fifth, the CASI-4R mania subscale 
complements the PGBI-10M by having different items. Finally, because other broad 
assessment packages such as the Child Behavior Checklist (CBCL; Achenbach & Rescorla, 
2001) and Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) do not have 
mania-specific scales, the CASI-4R potentially fills a niche by integrating a mania scale into 
a tool that simultaneously assesses more common issues such as ADHD, anxiety, and 
disruptive behavior disorders. Taken together, characteristics of the CASI-4R suggest that 
the CASI-4R mania subscale may have clinical utility in reliably and quickly providing 
information about manic symptoms before a more structured diagnostic evaluation for those 
at risk for BPSDs is administered. Because established measures already exist, it is 
important to benchmark the CASI-4R mania subscale against one of the top-tier tools. If it 
performs comparably, the advantage of having a mania measure embedded in a general, 
broad assessment would give the CASI-4R mania subscale an advantage as a screener to 
assess for specific symptoms that may better discriminate BPSDs. If it performs 
substantially less well, then evaluating a two-stage assessment process, where a suggestive 
score on the CASI-4R mania subscale gets followed by a more focused evaluation could be 
considered (Youngstrom, Jenkins, Jensen-Doss, & Youngstrom, 2012).
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The present study examined discriminative and diagnostic validity of the CASI-4R mania 
subscale in differentiating youth with BPSDs from those with non-BPSD diagnoses in an 
outpatient setting. All youth in the sample were evaluated using a gold standard diagnostic 
assessment, the Schedule of Affective Disorders and Schizophrenia for Children (KSADS-
PL-W; Findling et al., 2010), providing the opportunity to compare discriminative ability of 
the CASI-4R mania subscale with the PGBI-10M against DSM-IV-TR diagnoses. We also 
estimated multi-level diagnostic likelihood ratios (DLRs) to facilitate clinicians’ use of the 
mania subscale in the assessment of pediatric BPSDs (Straus et al., 2011). Finally, in 
keeping with teacher report as a possible accurate indicator of pediatric BPSD (Carlson & 
Klein, 2014), we also explored the teacher report of the CASI-4R mania subscale by running 
discriminative and incremental validity analyses. Due to its psychometric properties and 
clear mapping of DSM-IV-TR BPSD diagnoses (American Psychiatric Association, 2000; 
Sprafkin, Gadow, Salisbury, Schneider, & Loney, 2002), we hypothesized the CASI-4R 
mania subscale would discriminate pediatric BPSDs with accuracy similar to well-
established scales such as the PGBI-10M (Youngstrom et al., 2005).
Method
Participants and procedures
This study is a secondary analysis of baseline assessment data from the Longitudinal 
Assessment of Manic Symptoms (LAMS) study, a NIMH-supported prospective cohort 
study examining children with elevated symptoms of mania (ESM). Participants were 707 
youth (465 male, mean age = 9.34) and their caregivers recruited from December 2005 to 
December 2008 (Horwitz et al., 2010). The present study includes 681 caregivers who 
completed both the PGBI-10M and CASI-4R mania subscale at baseline. Nine child 
outpatient mental health clinics in four university-affiliated LAMS sites recruited 
participants (Case Western Reserve University, Cincinnati Children’s Medical Center, the 
Ohio State University and the University of Pittsburgh Medical Center/Western Psychiatric 
Institute and Clinic). Parents/guardians of all eligible children between age 6 and 12 
completed the Parent General Behavior Inventory-10 Item Mania Scale (PGBI-10M) to 
screen for elevated symptoms of mania (ESM+). All youth who scored more than 12 on the 
PGBI-10M were invited to participate in the study. For those who scored 11 or less, a 
matched group (approximately one-fifth of the ESM- sample) of children (similar in age, 
sex, race/ethnicity and insurance status) were recruited. Horwitz et al. (2010) provides 
details about subject ascertainment and the rationale for the cut score of 12 on the 
PGBI-10M. Exclusion criteria were: (a) if youth or caregiver did not speak English; or (b) if 
there was evidence that manic symptoms were due to a general medical condition. Data 
collection was planned before gathering the index tests (i.e., parent-report measures) and 
reference standard (i.e., diagnostic interview). Caregivers provided written consent, and 
youth provided assent. Caregivers provided demographic information, including age, sex, 
race, ethnicity, and health insurance status (Findling et al., 2010). Bachelors, masters and 
doctoral level interviewers trained by rating taped interviews and then leading 
administrations with experienced interviewers concurrently serving as raters.
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Measures
Index Tests
Child and Adolescent Symptom Inventory-Revised (CASI-4R) Mania Subscale: The 
CASI-4R is a 163-item caregiver-completed pencil-and-paper rating scale for evaluating 
youth five to 18 years old. The CASI-4R combines symptom modules from the Child 
Symptom Inventory-4 (CSI-4) and Adolescent Symptom Inventory-4 (ASI-4) (Gadow & 
Sprafkin, 2005), and sums to generate a global severity score for each disorder using 
symptom counts. Nine items measure manic symptoms (questions L98–L106), addressing 
DSM mania criteria using queries about cheerful and irritable mood, activity level, sleep 
need, talkativeness, distractibility, and items that try to address flight of ideas, grandiosity 
and severe impulsivity. Item severity scores range from 0 (never) to 3 (very often). A 
specific symptom is considered to be clinically relevant if it is rated by the clinician to be 
either happening often or very often. When the total symptom count is equal or exceeds the 
number of symptoms required to meet a DSM-IV-TR bipolar disorder diagnosis, the child 
then screens positive for the disorder. The CSI-4 and ASI-4, from which the CASI-4R was 
derived, have shown satisfactory internal consistency, test-retest reliability and convergent 
validity compared to corresponding scales of the Child Behavior Checklist (Achenbach & 
Rescorla, 2001) and the Conner’s Parent Rating Scale (Conners, 1997). The parent-report 
CASI-4R mania subscale has demonstrated adequate psychometric properties, with 
Cronbach’s alphas of .86 – .89 (Gadow & Drabick, 2012; Gadow & Sprafkin, 2008).
Parent General Behavior Inventory (PGBI-10M): The PGBI-10M (Youngstrom, Frazier, 
et al., 2008) is a 10-item parent-report instrument derived from the parent version 
(Youngstrom et al., 2001) of the General Behavior Inventory (GBI; Depue et al., 1981); it 
collects hypomanic, manic and biphasic symptoms. The PGBI-10M kept the 10 items best at 
discriminating bipolar disorder from other diagnoses (Youngstrom, Frazier, et al., 2008). 
Item scores range from 0 (never or hardly ever) to 3 (very often or almost constantly). Total 
scores range from 0 to 30, with higher scores indicating greater severity. In the present study, 
internal consistency for the PGBI-10M (Cronbach’s alpha = .87) was good.
Reference Standard: Semi-structured diagnostic interview using the Schedule of 
Affective Disorders and Schizophrenia for Children (KSADSPL-W): All participants 
and their families completed a semi-structured diagnostic interview, the KSADSPL-W, 
which combined the KSADS-Present and Lifetime Episode (K-SADS-PL; Kaufman et al., 
1997) and the mood disorders module from the Washington University KSADS (WASH-U-
KSADS; Geller, Warner, Williams, & Zimerman, 1998; Geller et al., 2001). The mood 
disorders module of the WASH-U-KSADS includes additional symptoms and associated 
features of bipolar spectrum disorders as per DSM-IV-TR. The LAMS study used the 
Course of Bipolar Youth (COBY) criteria for BP-NOS: (1) elated mood and at least two 
associated symptoms of mania (such as racing thoughts, pressured speech, thoughts of 
grandiosity, decreased need for sleep), or irritable mood with at least three associated 
symptoms of mania; (2) an associated change in functioning; (3) symptoms needed to be 
present for at least four hours within a 24-hour period; and (4) the participant must have had 
at least four episodes of four-hour duration or a total of four days meeting the above criteria 
(Axelson et al., 2006). A highly trained research assistant administered the interview 
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(training included watching previously taped administrations of the WASH-U-KSADS). 
Inter-rater reliabilities were strong, with kappas of .82 for WASH-U-KSADS diagnoses and .
93 for BPSD diagnoses. A licensed child psychiatrist or psychologist confirmed all 
diagnoses. The child psychiatrist or psychologist were blind to scores on the PGBI-10M and 
the CASI-4R.
Data Analytic Plan
Preliminary analyses. Because the sampling plan followed an a priori design, we weighted 
primary analyses by site to adjust for the sampling by ESM status (Van Meter et al., in 
press). Descriptive statistics summarized clinical and demographic characteristics of the 
sample, while t-tests and chi-square analyses tested for significant differences between youth 
with BPSD and other youth in the sample. Although the primary analyses used 
nonparametric methods, it is still important to examine score distributions for evidence of 
degeneracy (Youngstrom, 2014; Zhou, Obuchowski, & McClish, 2011). Degeneracy refers 
to distributions that either (a) have a bimodal score distribution; (b) have regions where 
score frequencies fail to progress monotonically (Zhou et al., 2011); or (c) the comparison 
group has a subset of cases with scores more extreme than the BPSD group on otherwise 
valid indicators. When degeneracy occurs, it can result in inaccurate estimates of test 
accuracy (Zhou et al., 2011). Low scoring cases were undersampled by design, so all 
subsequent analyses weighted the ESM- cases to adjust for the sampling to produce 
unbiased results (Van Meter et al., in press). Youngstrom (2014) makes a strong case for 
representative samples when calculating DLRs to avoid inaccuracies that may result from a 
biased sample. All results are based on the weighted analyses unless otherwise stated. 
Analyses were done using SPSS-Version 22.0 and the pROC package in R (R Development 
Core Team, 2014; Robin et al., 2011).
Receiver operating characteristic (ROC) analysis: ROC curves depict the balance 
between the probability of a true positive test result for those who have the target condition 
(known as sensitivity) and the probability of a true negative test result for those who do not 
have the condition (known as specificity). In this study, ROC analyses quantified the ability 
of each scale to distinguish cases with BPSD (which included BP-I, BP-II, cyclothymic 
disorder and BP-NOS) from all other cases (e.g., individuals with ADHD or anxiety 
disorders).
The area under the curve (AUC) is an effect size quantifying diagnostic accuracy of test 
scores. An AUC of 1.0 would indicate that the test performed with perfect diagnostic 
accuracy, while an AUC of .50 would indicate chance performance (Obuchowski, 2003; 
Zhou et al., 2011). Standard guidelines for evaluating AUC values include: (a) < .70 = poor, .
70 – .79 = fair; .80 – .89 = good, and .90 – 1.00 = excellent (Swets, Dawes, & Monahan, 
2000). Values higher than .90 in mental healthcare contexts are often the result of design 
flaws, such as comparing clinical cases to healthy controls (Youngstrom et al., 2015; 
Youngstrom, Meyers, Youngstrom, Calabrese, & Findling, 2006). Asymmetric 95% 
confidence intervals quantified uncertainty around the AUCs. Furthermore, the Venkatraman 
test (2000), computed in R version 3.2.2, compared the AUCs for each subscale to see if any 
subscale performed significantly better than others in discriminating youth with BPSD and 
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without BPSD. The Venkatraman test has an added advantage over confidence intervals in 
that it permits distinguishing between two ROC curves that have similar overall point 
estimates of areas but do not cross (Venkatraman, 2000). The Venkatraman test uses 
bootstrapping to repeatedly sample areas under each curve and compare ROC curves based 
on shape rather than numerical value alone.
Diagnostic Likelihood Ratios (DLRs): DLRs refer to the change in odds of the diagnosis 
based on assessment results. DLRs capture more detailed diagnostic information for 
decision making about individual cases. They repackage diagnostic sensitivity and 
specificity to help estimate posterior predictive values (Straus et al., 2011). Clinicians can 
combine DLRs with prior probability of the diagnosis (often the base rate of the diagnosis) 
by means of a probability nomogram, online calculators, or Bayes’ Theorem (Jaeschke, 
Guyatt, & Sackett, 1994; Youngstrom et al., 2014) to obtain an updated risk of the individual 
having the disorder. We estimated likelihood ratios for tertiles of score ranges (Jaeschke et 
al., 1994; Straus et al., 2011). This (a) preserved more diagnostic information from test 
results; (b) ensured that scales behaved monotonically (Guyatt & Rennie, 2002; Zhou et al., 
2011); and (c) reduced ambiguity for high-stakes clinical decision making. DLRs of .5 to 2 
alter probability to a small (and rarely important) degree; DLRs between 2 and 5 (or, 
conversely, 0.5–0.2) generate small (but sometimes important) changes in clinical 
probability; DLRs between 5.0 and 10.0 (or 0.1–0.2) reflect moderate shifts in pre- to 
posttest probability, and DLRs greater than 10 (or smaller than 0.1) are often clinically 
decisive (Straus et al., 2011).
Positive and negative predictive values: Positive predictive power describes the percentage 
of cases testing positive that have the diagnosis, while negative predictive power refers to the 
accuracy of negative test results. While these concepts are clinically helpful for clinicians, 
they change as a function of base rate, and are less preferred over DLRs. This is because 
DLRs use the concepts of sensitivity and specificity, which are not affected by the base rate 
and can be used in multiple clinical settings.
Logistic regressions: Hierarchical logistic regressions evaluated the strength of the 
CASI-4R mania subscale and PGBI-10M in predicting BPSD diagnosis in youth after 
adjusting for sex, age of child at baseline assessment, race (white versus nonwhite), any 
anxiety disorder, attention-deficit hyperactivity disorder, any disruptive behavior disorder 
diagnosis (conduct disorder, oppositional defiant disorder, disruptive behavior disorder NOS, 
intermittent explosive disorder, impulse-control disorder NOS, adjustment disorder with 
disturbance of conduct). Model 1 entered demographic variables, and Model 2 controlled for 
both demographic and diagnostic covariates. Finally, Model 3 entered the CASI-4R mania 
subscale variable and PGBI-10M scale separately in the last block. We reported the 
Nagelkerke R2 and the log-likelihood ratios as the main ways of describing fit and 
significance; we also reported classification accuracy for descriptive purposes, even though 
it is not a strong measure of model fit (Hosmer & Lemeshow, 2000).
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Results
Descriptive Statistics
Table 1 presents group differences between youth with BPSD and youth without BPSD by 
(a) sex; (b) race; (c) age; (d) CASI-4R and baseline PGBI-10M total scores; and (e) number 
of DSM-IV-TR Axis I diagnoses. The BPSD group had a significantly higher proportion of 
females and older youth. There were no significant differences in race (white vs nonwhite) 
by diagnostic group. The BPSD group scored higher on the CASI-4R and the baseline 
PGBI-10M, offering preliminary evidence of discriminative validity.
Diagnostic Efficiency Statistics
Table 2 presents findings from ROC analyses. Back-to-back histograms for all distributions 
did not indicate degenerate distributions or outliers (Youngstrom, 2014). AUC values 
quantified performance of the CASI-4R mania subscale for distinguishing between youth 
with BPSD from other youth. Both the CASI-4R mania subscale and the PGBI-10M scale 
attained medium-large effect sizes for validity at distinguishing BPSD-positive youth from 
BPSD-negative youth (CASI-4R mania subscale: AUC = .80, PGBI-10M: AUC = .79; p < .
0005). The Venkatraman test indicated that the two scales did not perform significantly 
differently, consistent with their close point estimates for AUC, p > .05.
Diagnostic Likelihood Ratios (DLRs)
To estimate DLRs, we divided scores on each subscale into three tertiles (low, indeterminate, 
high). We also reported sensitivity and specificity for the lower tertile and the higher tertile, 
and provided the relevant positive predictive value and negative predictive value. Table 2 
reports DLRs for the CASI-4R mania subscale and the PGBI-10M, and Table 4 provides 
optimal thresholds for P-GBI and CASI-4R mania scale scores. On the CASI-4R mania 
subscale, BPSD-positive youth were over four times as likely to score more than 14 than 
those who did not receive a BPSD diagnosis (DLR = 4.53). This cutoff score correctly 
classified about 37% (sensitivity) of youth with BPSD and 91% of youth without BPSD 
(specificity). Conversely, youth with BPSD were about 1/5 as likely to score 5 or below as 
those who were youth without BPSD (DLR =0.17). This cutoff range correctly classified 
about 90% (sensitivity) of youth with BPSD and 37% of youth without BPSD (specificity). 
On the PGBI-10M scale, youth with BPSD were about four times as likely to score 20 or 
above as youth without BPSD (DLR = 3.97). This cutoff score correctly classified about 
34% (sensitivity) of youth with BPSD and 93% of youth without BPSD (specificity). 
Conversely, youth with BPSD were also less than 1/5 as likely to score 6 or below as those 
who were youth without BPSD (DLR = 0.18). This cutoff range correctly classified about 
94% of youth with BPSD diagnoses (sensitivity) and 28% of youth without BPSD 
(specificity).
Incremental Validity of CASI-4R and PGBI-10M
Logistic regressions clarified the robustness of the CASI-4R mania subscale and PGBI-10M 
in predicting BPSD status, after controlling for demographic and common diagnostic 
comorbidities (Table 1). Model 1 controlled for demographic variables. The overall model 
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explained 16% of variance in BPSD status (Nagelkerke R2 = .16, p < .0005), and predicted 
BPSD status with 87% accuracy. BPSD status was associated with being female and 
increased age (ps < .0005). Being white did not predict BPSD status (p = 0.52). Model 2 
added diagnostic variables to determine if they predicted BPSD status above and beyond the 
variables in Model 1. Model 2 explained an additional 1.3% of the variance in BPSD status 
(p <.0005), and predicted BPSD status accurately 86% of the time. Of note, the 
improvement in R-squared and log-likelihood (or chi-squared) combined with no change in 
classification accuracy (or even slight decrease in accuracy) is an unusual, but known feature 
of logistic regression. ADHD (p = .09), anxiety disorder (p = .26) and oppositional defiant 
disorder (p = .05) did not predict BPSD status when controlling for demographic variables. 
Finally, Model 3 was analyzed twice separately, with the CASI-4R mania subscale and 
PGBI-10M, to determine if higher scores were more likely to predict BPSD status. First, 
higher CASI-4R mania scores predicted BPSD status (Wald = 134.34, p < .0005). The 
overall model with the CASI-4R mania subscale was significant (X2 = 288.54, p < .0005), 
explaining an additional 22% of the variance (ΔNagelkerke R2 = .22, total R2 = .38), and 
predicted BPSD status accurately 87% of the time. Second, higher PGBI-10M scores 
predicted BPSD status (Wald = 129.47, p < .0005). The overall model with the PGBI-10M 
scale was significant (X2 = 274.58, p < .0005), explained an additional 20% of the variance 
in BPSD status (ΔNagelkerke R2 = .20, total R2 = .37), and predicted BPSD status 
accurately 86.4% of the time. Third, higher PGBI-10M and P-GBI scores predicted BPSD 
status when entered into the model simultaneously: Wald (CASI mania) = 20.30, p < .0005; 
Wald (PGBI-10M) = 8.90, p < .01. The overall model with both scales was significant (X2 = 
113.61, p < .0005), explained an additional 23% of the variance in BPSD status 
(ΔNagelkerke R2 = .17, total R2 = .23), and predicted BPSD status accurately 77% of the 
time.
Sensitivity Analyses: Teacher report
The CASI-4R teacher report failed to show good validity for identifying cases with bipolar 
disorder, with an AUC of .54 (indicating that teacher report on the CASI-4R performed at 
about chance level when identifying youth with and without BPSDs). Teacher report scores 
on the CASI-4R were consistently lower than parent report when comparing the bipolar with 
ADHD group, as well as the bipolar without ADHD group, although teachers endorsed a 
moderate amount of CASI-4R items across all diagnostic groups (see Table 3). Both the 
caregiver CASI-4R mania scale and PGBI-0010M outperformed the teacher-reported 
CASI-4R mania subscale considerably, p < .001 (Venkatraman, 2000). Logistic regressions 
found no incremental value in combining teacher and caregiver report, before or after 
adjusting for age and sex.
Discussion
The present study evaluated diagnostic efficiency of the CASI-4R mania scale for detecting 
BPSD in youth aged 6–12 years seeking outpatient mental health services. The CASI-4R 
mania scale performed at a similar level as the P-GBI, a top-tier measure for discriminating 
cases with bipolar disorder. Clinicians should use the high risk range of 14+ on the CASI-4R 
mania scale (DLR = 4.53) as a reference point to be watchful for bipolar spectrum disorders. 
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Conversely, scores in the low-risk range (5 or lower) decrease the odds of a bipolar spectrum 
disorder (DLR = 0.17). A trained clinician should clarify the diagnosis by integrating 
collateral information (family history, environmental stressors, parent and peer report) or by 
administering a semi-structured diagnostic interview focused on mood episodes.
Although there are now a variety of rating scales with statistically significant discriminative 
validity for BPSD (Youngstrom et al., 2015), the CASI-4R could fill an important need in 
clinical practice. The CASI-4R content covers a broad range of DSM disorders, and it also 
contains a mania scale. Other instruments with broad content coverage, such as the ASEBA 
(Achenbach & Rescorla, 2001) and the SDQ (Goodman, 1997) do not include mania scales. 
Efforts to rationally or empirically build mania scales or composites post-hoc from these 
general psychopathology item sets produce results that perform similarly to using the 
Externalizing score to predict bipolar status (Diler et al., 2009; Kahana, Youngstrom, 
Findling, & Calabrese, 2003) and significantly less strong than performance of several scales 
that focus on symptoms specific to mania. Conversely, the best performing mania scales are 
stand alone tools that do not assess other common disorders or dimensions of functioning. 
The present study kept the CASI-4R mania subscale embedded in the regular, full length 
version, mimicking how clinicians might use it to obtain information about manic symptoms 
as part of an initial general intake. Analyses evaluated scale performance under clinically 
realistic conditions, directly comparing discriminative validity to one of the incumbent, best 
performing measures, the PGBI-10M.
Both the CASI-4R mania subscale and the PGBI-10M discriminate youth with BPSD from 
treatment-seeking youth with related and comorbid disorders equally well. DLRs for the 
CASI-4R mania subscale were similar to the PGBI-10M. Incorporating Bayesian methods as 
part of the assessment process enables clinicians to integrate multiple sources of data, 
improving predictions made about diagnosis and prognosis (Jenkins et al., 2011; Jensen-
Doss, Youngstrom, Youngstrom, Feeny, & Findling, 2014). DLRs can be integrated easily 
with local BPSD base rates to give clinicians a sense of how much an individual’s diagnostic 
picture changes for a given score. Other psychometric data (such as factor analysis results 
and AUCs) are helpful for evaluating whether or not to use a measure, while DLRs help the 
clinician apply results to an individual case: an increase or decrease in risk in an individual 
depends on test scores. Using DLRs also reduces the effects of cognitive biases and 
heuristics (Jenkins et al., 2011).
Discriminative accuracy of the CASI-4R mania scale changed substantially depending on 
informant. Teachers do not appear to have the same opportunity to observe manic symptoms, 
or at least to judge them accurately as parents do. The teacher mania scores showed similar 
moderate elevations across the different diagnostic groups. This is in marked contrast to the 
greater accuracy of teachers in noting symptoms of ADHD, which the school situation 
usually tends to elicit more dramatically than the less demanding home situation. Perhaps, 
similar to Tourette’s Disorder, the school situation has a suppressing effect on manic 
symptoms that are more unrestrained at home. The poor discriminative performance of 
teacher report about manic symptoms has been a consistent finding across multiple measures 
and samples (Youngstrom et al., 2015; Youngstrom, Joseph, & Greene, 2008). At the same 
time, it is worthwhile for the clinician to inquire in cases where the parent and teacher report 
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diverge extemely: Disagreement can signal situationally specific problems, and cases where 
parent and teacher agree about the presence of manic symptoms tend to be substantially 
more impaired (Carlson & Youngstrom, 2003).
Clinical Application and Vignette
Because base rates of pediatric BPSD differ across clinical settings (Youngstrom, Freeman, 
& Jenkins, 2009), test results can contribute to accurate diagnosis by systematically 
assessing symptoms in a standardized fashion. DLRs help decrease false-positive diagnoses 
(Harrell, Califf, Pryor, Lee, & Rosati, 1982). Decreasing false-positive diagnoses is 
especially important in settings where BPSDs are uncommon (Jenkins et al., 2011). Taken 
together, the presentation of ROC analysis and DLRs make it easier for clinicians to use 
Bayesian methods to integrate test results with other risk factors, generating posterior 
probabilities (Jenkins et al., 2011; Straus et al., 2011). A clinical vignette illustrates this 
process:
Timothy, a 12 year-old Caucasian boy, was referred to a mood disorders clinic by his middle 
school counselor. The referring counselor describes Timothy as high energy and ready to go. 
His teachers describe him as always out of his seat, wandering the room, and talking 
extremely fast. His mother, Emily, describes Timothy at home as being increasingly restless. 
Emily is worried about her son because his father is diagnosed with bipolar I disorder. 
Timothy’s father takes lithium and he has responded well when adherent to medication. 
Emily completed the CASI-4R as part of Timothy’s intake battery; the mania scale raw 
score was 16.
Probability nomograms can be used to estimate the likelihood an individual has a particular 
diagnosis, by combining information such as base rates, risk factors and test scores, through 
drawing lines across the nomogram. Using a probability nomogram (see Figure 2), we begin 
with a base rate for pediatric BPSD of 10%, which is consistent with the referral pattern at 
outpatient mood clinics (DelBello & Geller, 2001; Weintraub et al., 2014). Next, we 
incorporate the knowledge that Timothy’s father has a diagnosis of bipolar disorder, which 
increases Timothy’s risk of BPSD by about 5 times (Youngstrom et al., 2009). Drawing a 
straight line from the base rate through the number 5 gives us a posterior probability risk for 
BPSD of 35.7%. Next, we mark the new probability of 36% on the nomogram, and 
incorporate the DLR of 4.53 associated with Timothy’s score of 16 on the CASI-4R mania 
subscale. Drawing a straight line from the base rate through the number 4.53 gives us a 
posterior probability risk of 71.6% of Timothy having a BPSD. Additional information 
sources would refine the posterior probability of a BPSD diagnosis. Our next step will be to 
confirm the diagnosis of a BPSD through a structured or semi-structured diagnostic 
interview, or adding prospective tracking of his mood and energy (Denicoff et al., 1997). 
Conversely, if Timothy had scored 4 on the CASI-4R mania subscale, it would offset the risk 
conferred by his family history. The posterior probability risk for BPSD given Timothy’s 
family history would still be 36%. When we apply Timothy’s low score of 4 with a 
corresponding DLR of 0.17, the risk is changed to a negligible 8.6%. If Timothy had a low 
score combined with a negative family history, he would have a revised probability of < 2%, 
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indicating that a diagnosis of pediatric BPSD is unlikely, and that other diagnostic 
hypotheses deserve greater consideration.
DLRs are not intended to be used in isolation to make a diagnosis, but they provide a 
signpost that clinicians can use to combat cognitive biases and heuristics. In a typical 
clinical scenario, in which a caregiver (parent or otherwise) brings a child in for assessment 
and treatment, the CASI-4R mania subscale will help the clinician to quickly estimate the 
likelihood of a BPSD versus the symptoms being due to ADHD or another disorder after 
inquiring for lifetime symptoms.
Though the CASI-4R mania subscale was found to have clinical utility in the current study, 
we note that the CASI-4R questionnaire is based on DSM-IV-TR criteria. The changes to the 
DSM-5 mania criteria (American Psychiatric Association, 2013) were minor in terms of 
impact on scale composition. The new criteria focus on disturbance of mood and energy, 
which does not require a new item, but rather a tweak of the interpretive algorithm to make 
energy change a required element. DSM-5 also dropped the word pleasurable from criterion 
B.7, “Excessive involvement in activities that have a high potential for painful 
consequences.” Other than these minor changes, other symptom criteria remain the same. 
Therefore, it is unlikely that the statistical performance of the scale would change 
substantially.
We also note that the CASI-4R questionnaire does not include a specific time frame in the 
instructions (Circle which rating best describes your child’s overall behavior). While the 
time frame being lifetime and/or worst episode helps increase its sensitivity to screening for 
manic symptoms, it results in poorer specificity about the length and history of manic 
symptoms in youth. When following up after using the CASI-4R mania scale, clinicians 
should first inquire for lifetime symptoms (crucial to establishing a DSM diagnosis) and 
proceed to inquire about current manic symptoms (crucial to guiding acute intervention).
Strengths & Limitations
The LAMS sample is reasonably large and enriched for youth with manic symptoms 
although the majority do not have a bipolar spectrum diagnosis. Children frequently met 
criteria for multiple disorders, which makes the study more clinically generalizable. Initial 
sample selection based on a GBI-10M threshold entailed the use of weighting to ensure that 
results were not biased. With more resources, it would have been valuable to interview all 
low scorers rather than only following a subset. Second, the LAMS sample only included 
outpatient mental health centers that were associated with university partners. As such, the 
sample did not include children whose parents may have sought mental care from other 
types of settings, such as inpatient settings or private practices. Third, the LAMS sample had 
parent report as one of the main sources of information in the diagnostic interview. A recent 
meta-analysis (Youngstrom, Genzlinger, et al., 2015) suggested that interviews relying 
solely on caregivers produce artificially higher agreement with caregiver report on checklists 
(the Hedge’s g inflates by .6). While the LAMS protocol includes direct observation of 
youth, the results are still likely to be closer to parent-only results than to what we would 
find with adolescents. This limitation also generalizes to clinical practice, where diagnoses 
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are likely to be heavily informed by caregiver report. Last, the bulk of the sample was 
collected from the Midwest, which may make it less generalizable to the population at large.
Conclusion
This study investigated discriminative validity of the CASI-4R mania subscale for detecting 
BPSDs in youth and compared it against the PGBI-10M, an established screening tool for 
pediatric BPSDs. The CASI-4R is a broad assessment tool covering a range of diagnoses 
common in an outpatient setting. The broad nature of the CASI-4R makes it an appealing 
screening tool and inclusion of a mania subscale makes a strong case for including this 
instrument in an assessment battery rather than diagnosis-specific self-report scales.
Elevated scores on the CASI-4R mania subscale predict a higher posterior probability of 
pediatric BPSD and help clarify case conceptualization, particularly when integrated with 
other sources of information (such as base rate and family history). Similarly, low scores are 
helpful in predicting a decreased posterior probability of pediatric BPSD. Present results 
should encourage clinical practitioners to: (1) track local base rates of diagnoses and 
common presenting problems, as they could be combined with DLRs to generate a posterior 
probability estimate of the disorder for cases; (2) select assessment tools with demonstrated 
discriminative validity based on statistical tools such as ROC analyses and DLRs, and (3) 
have DLRs available along with interpretive tools, such as the probability nomogram 
(Youngstrom, 2014), probability calculator websites or apps. Taken together, these steps help 
clinicians reduce potential cognitive biases arising from deciding on a diagnosis based on 
clinical impressions (Jenkins et al., 2011).
Finally, when using a clinically meaningful comparison group, the CASI-4R mania subscale 
demonstrates good diagnostic accuracy, with an effect size similar to the best available 
established measure, the PGBI-10M. Given its combination of similar performance with 
simultaneous coverage of a broad range of other disorders, the CASI-4R appears to be a 
good alternative to the strategy of pairing another broad measure, such as the CBCL 
(Achenbach & Rescorla, 2001) or the SDQ with a mania measure such as the PGBI-10M 
(Youngstrom, Frazier, et al., 2008) after the clinician has ascertained the presence of lifetime 
symptoms0.
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Figure 1. 
Receiver operating characteristic analyses comparing baseline CASI-4R mania subscale 
parent report, CASI-4R mania subscale teacher report, and PGBI-10M.
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Figure 2. Using a probability nomogram to interpret scores on the CASI-4R mania subscale
Note. Timothy is a 12 year-old Caucasian boy referred due to high energy, restlessness, 
irritable mood, and aggressive behavior. According to his mother, the biological father has 
bipolar I disorder. Mom completed the CASI-4R mania subscale, yielding score of 16, 
which is in the High Risk range.
Steps in using the nomogram (adapted from Strauss, Richardson, Glasziou & Haynes, 2011):
(1) Select the pre-test probability (usually base rate of disorder) and mark on the 
first vertical line from the left. In this example, assume that the base rate of 
pediatric bipolar disorder is 10%. To find base rates that correspond to your 
clinical setting, refer to online resources, such as an online assessment portfolio, 
found here.
(2) Find the diagnostic likelihood ratio (DLR) associated with the risk factor and 
plot on the second vertical line. In this example, bipolar disorder in a first degree 
relative (e.g. father, mother, or full sibling) has a DLR of 5.0 (Youngstrom, 
Freeman, & Jenkins, 2009).
(3) Connect the dots from (1) and (2), and extend across the third line to find a post-
test probability estimate of 36%.
(4) To add new information, repeat the process by using information from step (3) 
as the new starting point (shown via dotted lines).
(5a) High risk scenario: A raw score of 16 on the CASI-4R mania subscale maps 
onto High Risk, which has a DLR of 4.53 (see Table 2).
(6a) Connect the dots from (4) and (5a) to find a post-test probability of 72%. You 
can also multiply the DLRs together and map them onto one nomogram (e.g. 
4.53 * 5 referring to example above).
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(5b) Alternate, low risk scenario: If the raw score on the CASI had be a 4 instead of 
a 16, that would be in the low-risk stratum, and the DLR would be 0.17. This 
would get plotted on the middle line of the nomogram.
(6b) Connecting the dots from (4) and (5b) would yield a post-test probability of 9%. 
This illustrates that the CASI is capable of moving cases with moderate risk, due 
to family history, back into low probabilities or up into moderately elevated 
ranges, but not high enough to initiate treatment for bipolar without additional 
clinical information.
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Table 1
Demographics
Variable Any BPSD (n = 160) No BPSD (n = 521) Test statistic p
Age in years (Mean, SD) 9.78 (2.05) 9.20 (1.82) t(241) = 3.18a <.001
Male
n = 90 n = 375
X2(1) = 13.98 <.001
(56.3%) (72%)
Race (White)
n = 111 n = 331
X2(1) = 1.83 .18
(69.4%) (63.5%)
Number of DSM-IV-TR Axis I diagnoses (Mean, SD) 2.89 (1.28) 2.36 (1.26) d = .42 <.001
Any anxiety disorder diagnosis
n = 49 n = 161
X2(1) = .004 .95
(30.6%) (30.9%)
Any ADHD diagnosis
n = 115 n = 418
X2(1) = 2.08 .15
(71.9%) (80.2%)
Any ODD diagnosis
n = 68 n = 292
X2(1) = 5.87 .02
(42.5%) (56%)
Mean (SD)
CASI-4R Mania Subscale 12.23 (5.71) 7.76 (5.62) d = .79 <.001
PGBI-10M 16.71 (6.03) 11.70 (7.08) d = .80a <.001
Teacher CASI-4R Maniab 8.14 (6.15) 7.40 (6.32) d = .12 .269
a
variances unequal, Levene’s Test p < .05.
b
For teacher data, n = 116 cases with BPSD, and n = 331 other.
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Table 3
Descriptive statistics for P-GBI, Parent and Teacher CASI mania scores split by diagnostic groups
Variable Mean PGBI-10M score (SD) Mean Parent CASI mania score (SD)
Mean Teacher CASI mania score 
(SD)
Bipolar with ADHDa 16.78 (6.04)a 12.31 (5.71) 7.40 (6.31)
Bipolar without ADHDa 15.96 (5.90) 11.40 (5.52) 6.98 (6.78)
ADHD without Bipolar 12.10 (6.98) 8.27 (5.72) 8.18 (6.08)
No Bipolar diagnosis 11.65 (7.07) 7.74 (5.61) 7.40 (6.32)
Neither Bipolar Nor ADHDb 9.50 (9.35) 3.71 (3.93) 8.25 (6.20)
a
Both groups (bipolar with and without ADHD) had higher mean PGBI-10M and mean parent CASI mania scores than the ADHD group without 
bipolar disorder.
b
The “Neither Bipolar Nor ADHD” group included youths with all other diagnoses, predominantly disruptive behavior disorders.
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